PLA2G4A and glioblastoma: Nowadays, targeting multiple pathways implicated in glioblastoma metabolism is considered an increasingly effective therapeutic strategy, and cPLA2 has long been considered in the context of metabolic reprogramming, which is recognized as a hallmark of cancer [28].